| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.08B | +17.9% |
| Cost of Revenue | $574.4M | +25.2% |
| R&D Expense | $393.4M | +2.0% |
| SG&A Expense | $737.3M | -8.0% |
| Operating Income | -$593.5M | +30.6% |
| Interest Expense | $19.6M | +5.5% |
| Pre-tax Income | -$632.6M | +24.9% |
| Income Tax | -$9.1M | +96.3% |
| Net Income | -$623.5M | -4.7% |
| EPS (Basic) | -$3.54 | -1.7% |
| EPS (Diluted) | -$3.54 | -1.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $242.5M | -23.1% |
| Short-term Investments | $389.6M | -45.5% |
| Accounts Receivable | $158.0M | -27.0% |
| Inventory | $118.3M | +12.6% |
| Current Assets | $982.3M | -31.1% |
| Total Assets | $6.23B | -6.9% |
| Current Liabilities | $412.7M | -20.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$223.6M | -118.7% |
| Capital Expenditures | $214.5M | +58.0% |
| Investing Cash Flow | $74.1M | +106.8% |
| Financing Cash Flow | $76.5M | +802.8% |
| Free Cash Flow | -$438.0M | -84.0% |
| Total Liabilities |
| $3.18B |
| -3.4% |
| Stockholders' Equity | $3.04B | -10.2% |